KANEKA CORPORATION (KANKF) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

—

MomentumView details →

1D Return

—

YTD Return

—

RSI (14)

—

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

—

RSI (14)

—

MomentumView details →

1D Return

—

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

802.43B

Net Income (TTM)

26.01B

Op. CF (TTM)

—

Latest newsMore news →

Kaneka Corporation announced that its Kaneka Ubiquinol ingredient won the Ingredient of the Year: Healthspan Award at the NutraIngredients-Asia Awards 2026 in Bangkok.2d ago

CSIR-SARI began field trials of KANEKA, a seed-treatment bio-stimulant developed by KANEKA Corporation of Japan, on maize, soybean, and groundnut at Nyankpala, Ghana, to evaluate its performance under local conditions.11d ago

Latest newsMore news →

Kaneka Corporation announced that its Kaneka Ubiquinol ingredient won the Ingredient of the Year: Healthspan Award at the NutraIngredients-Asia Awards 2026 in Bangkok.2d ago CSIR-SARI began field trials of KANEKA, a seed-treatment bio-stimulant developed by KANEKA Corporation of Japan, on maize, soybean, and groundnut at Nyankpala, Ghana, to evaluate its performance under local conditions.11d ago